This article introduces year-based h-indices as a tool to produce easy-to-use research overviews. Based on PubMed data, a general framework is constructed to study the development of molecular research in the context of nervous system diseases. It is shown which molecular substances are the centre of attention and which have passed their peak. Year-based h-indices have the following interesting features for representing changes in a field or discipline: flexibility, sensitivity to dynamic changes, fluctuation detection and trend detection.
LeydesdorffL. The delineation of nanoscience and nanotechnology in terms of journals and patents: A most recent update. Scientometrics2008; 76(1): 159–167.
2.
SamoylenkoIChaoTCLiuWC. Visualizing the scientific world and its evolution. Journal of the American Society for Information Science and Technology2006; 57(11):1461–1469.
3.
SkupinABiberstineJRBörnerK. Visualizing the topical structure of the medical sciences: A self-organizing map approach. PLoS ONE2013; 8(3): e58779.
4.
van EckNJWaltmanL. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics2010; 84(2): 523–538.
5.
HirschJE. An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences of the USA2005; 102(46): 16569–16572.
6.
LiangLMRousseauR. A general approach to citation analysis and an h-index based on the standard impact factor framework. In: LarsenBLetaJ (eds) ISSI 2009; 12th International Conference on Scientometrics and Informetrics, Rio de Janeiro, Brazil, 2009, pp. 143–153. Rio de Janeiro: BIREME & Federal University of Rio de Janeiro.
7.
BraunTGlänzelWSchubertA. A Hirsch-type index for journals. Scientometrics2006; 69 (1): 169–173.
8.
BanksMG. An extension of the Hirsch index: Indexing scientific topics and compounds. Scientometrics2006; 69(1): 161–168.
9.
LiuYXRousseauR. Properties of Hirsch-type indices: The case of library classification categories. Scientometrics2009; 79(2): 235–248.
10.
EggheL. The Hirsch index and related impact measures. Annual Review of Information Science and Technology2010; 44(1): 65–114.
11.
AlonsoSCabrerizoFJHerrera-ViedmaE. H-Index: A review focused in its variants, computation and standardization for different scientific fields. Journal of Informetrics2009; 3(4): 273–289.
12.
JinBHLiangLMRousseauR. The R- and AR-indices: Complementing the h-index. Chinese Science Bulletin2007; 52(6): 855–863.
CescaFBaldelliPValtortaF. The synapsins: Key actors of synapse function and plasticity. Progress in Neurobiology2010; 91(4): 313–348.
15.
CrewsLMasliahE. Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Human Molecular Genetics2010; 19 (R1): R12–20.
16.
ZhaoZMKierLBBuckGA. Systems biology: Molecular networks and disease. Chemistry & Biodiversity2012; 9(5): 841–847.
17.
HuXJZhaoDZStrotmannA. Mapping molecular association networks of nervous system diseases via large-scale analysis of published research. PLoS One2013, 8(6): e67121; doi:10.1371/journal.pone.0067121
18.
BaranziniSE. Revealing the genetic basis of multiple sclerosis: Are we there yet?Current Opinion in Genetics and Development2011; 21(3): 317–324.
LinLHungsMMignotE. Narcolepsy and the HLA region. Journal of Neuroimmunology2001; 117(1–2): 9–20.
21.
FinkelRS. Read-through strategies for suppression of nonsense mutations in Duchenne/Becker muscular dystrophy: Aminoglycosides and ataluren (PTC124). Journal of Child Neurology2010; 25(9): 1158–1164.
22.
GrandyJK. Biomarkers and gene mutations as aids for detecting AD early. Journal of American Academy of Physician Assistants2011; 24(6): 56–57.
23.
LeandroJSarasteJLeandroP. The G46S-hPAH mutant protein: A model to study the rescue of aggregation-prone PKU mutations by chaperones. Molecular Genetics and Metabolism2011; 104(suppl.): S40–S44.
24.
ScriverCR. The PAH gene, phenylketonuria, and a paradigm shift. Human Mutation2007; 28(9): 831–845.
25.
ChioccaEA. Gene therapy: A primer for neurosurgeons. Neurosurgery2003; 53(2): 364–373.
26.
GitlerADBevisBJShorterJ. The Parkinson’s disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proceedings of the National Academy of Sciences of the USA2008; 105(1): 145–150.
27.
LarnerAJDoranM. Genotype–phenotype relationships of presenilin-1 mutations in Alzheimer’s disease: An update. Journal of Alzheimer’s Disease2009; 17(2): 259–265.
28.
WolkDADickersonBC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease. Proceedings of the National Academy of Sciences of the USA2010; 107(22): 10256–10261.
29.
OlanowCWMcNaughtK. Parkinson’s disease, proteins, and prions: Milestones. Movement Disorder2011; 26(6): 1056–1071.
MegiorniFPizzutiA. HLA-DQA1 and HLA-DQB1 in celiac disease predisposition: Practical implications of the HLA molecular typing. Journal of Biomedical Science2012; 19(1): 88–97.
